GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
After meeting with the U.S. Food and Drug Administration (FDA), it has been determined that the regulatory path forward for uproleselan in relapsed and refractory (R/R) Acute Myeloid Leukemia...
Company exploring path forward for uproleselan in multiple AML settings based on observed efficacy results, including clinically meaningful results in primary refractory AML, and significant...
GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0073 | -4.28152492669 | 0.1705 | 0.179 | 0.1614 | 652555 | 0.16476953 | CS |
4 | -0.0293 | -15.2207792208 | 0.1925 | 0.1977 | 0.155 | 675216 | 0.17003217 | CS |
12 | -0.1128 | -40.8695652174 | 0.276 | 0.33 | 0.155 | 1220128 | 0.21866022 | CS |
26 | -2.8068 | -94.5050505051 | 2.97 | 3.18 | 0.155 | 2741426 | 0.41567474 | CS |
52 | -1.2268 | -88.2589928058 | 1.39 | 3.5299 | 0.155 | 1491249 | 0.59500479 | CS |
156 | -2.1268 | -92.8733624454 | 2.29 | 4.16 | 0.155 | 787732 | 1.10482184 | CS |
260 | -4.1868 | -96.2482758621 | 4.35 | 6.72 | 0.155 | 686263 | 1.7972016 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.